Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05661383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Olfactory and Brain Stimulations in Treatment-resistant Depression

Study acronym: COBRA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2, 2023 to Jan 27, 2024
    • Study sites: 0 to 1
    • Primary completion date: Oct 2, 2026 to Jan 27, 2027
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Hôpital le Vinatier
47 trials monitored
See 1 trial at risk
Depression
3,055 trials monitored
See 173 trials at risk
This is a prospective, randomized, double-blind, parallel-group controlled trial. The aim of this research project is to compare the clinical benefits achieved in patients with major depressive disorder (MDD) following two types of intervention: iTBS active alone or iTBS active combined with olfactory stimulations.
Trial Details
NCT Number NCT05661383
Lead Sponsor Hôpital le Vinatier
Collaborators: Fondation de France
Conditions
(from sponsor)		 Treatment-resistant Depression
Related terms Anhedonia, Depression, Depressive Disorder, Treatment-Resistant
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov